RANDOLPH TOLLEY: Open Payments
NPI 1124718796 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,345 in 196 payments from 17 companies in 2025. Trend: 2023 $327 · 2024 $3,987 · 2025 $4,345
Food & beverage: $4,345
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 43 | $1,060 |
| ABBVIE INC. | 40 | $826 |
| Novartis Pharmaceuticals Corporation | 15 | $406 |
| Janssen Biotech, Inc. | 13 | $401 |
| UCB, Inc. | 9 | $299 |
| ANI Pharmaceuticals, Inc. | 16 | $236 |
| GlaxoSmithKline, LLC. | 8 | $231 |
| Aurinia Pharma U.S., Inc. | 25 | $162 |
| Alexion Pharmaceuticals, Inc. | 3 | $154 |
| Lilly USA, LLC | 5 | $114 |
Products named: TAVNEOS, RINVOQ, TREMFYA, COSENTYX, Bimzelx, PURIFIED CORTROPHIN GEL, BENLYSTA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
